Domperidone Expanded Access Treatment Program

12 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional Vomiting

NCT00252993 ·Status: TERMINATED ·Phase: PHASE2

Effect of 10mg Domperidone on Gastric Emptying of a High-fat Meal and Appetite Sensations in Healthy Adults

NCT01347814 ·Status: COMPLETED ·Phase: NA

Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial

NCT01149369 ·Status: COMPLETED ·Phase: PHASE2

Nortriptyline for Idiopathic Gastroparesis

NCT00765895 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.

NCT06899217 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)

NCT03268941 ·Status: COMPLETED ·Phase: PHASE2

Washed Microbiota Transplantation for Diabetic Gastroparesis

NCT06340217 ·Status: RECRUITING ·Phase: NA

Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis

NCT02970968 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance

NCT01039805 ·Status: COMPLETED ·Phase: PHASE2

Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis

NCT02025751 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Domperidone in Pediatric Participants With Nausea and Vomiting Due to Acute Gastroenteritis

NCT02699385 ·Status: TERMINATED ·Phase: PHASE3

Synergistic Gut-brain Axis Modulation Via Vagal Stimulation and Support Therapy in Functional Dyspepsia

NCT06360900 ·Status: RECRUITING ·Phase: NA

Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis

NCT01262898 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

NCT02357420 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.

NCT00733551 ·Status: COMPLETED ·Phase: PHASE1

Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention

NCT01126034 ·Status: COMPLETED ·Phase: NA

Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study

NCT01934192 ·Status: TERMINATED ·Phase: PHASE2

Study of Promethazine for Treatment of Diabetic Gastroparesis

NCT02130622 ·Status: TERMINATED ·Phase: PHASE2

Prokinetic Drugs and Enteral Nutrition

NCT00916591 ·Status: UNKNOWN

Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis

NCT02025725 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis

NCT04026997 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis

NCT00845858 ·Status: COMPLETED ·Phase: PHASE2

Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients

NCT01117376 ·Status: TERMINATED ·Phase: PHASE2

Treatment of Orthostatic Hypotension in Autonomic Failure

NCT00223691 ·Status: COMPLETED ·Phase: PHASE1

Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe Gastroparesis

NCT05270460 ·Status: COMPLETED ·Phase: PHASE2